CELTAXSYS, INC.

CLOSED

1700 Owens St, 佐治亚州富尔顿县, 佐治亚州, United Stateswww.celtaxsys.comPrivate11–50 employeesEstablished: 2004-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2004

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

66.7%

Phase 2

33.3%

Trial Status Distribution

Completed

100.0%

Clinical Trials

Trials sponsored by this organization (6)

Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-Acebilustat (CTX-4430)

Phase 1

Completed

interventional

Apr 20196 participants

EMPIRE CF: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 in Adult Cystic Fibrosis (CF) Patients

Phase 2

Completed

interventional

Oct 2015200 participants

CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris

Phase 2

Completed

interventional

Apr 2015124 participants

Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam

Phase 1

Completed

interventional

Sep 201420 participants

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients

Phase 1

Completed

interventional

Sep 201317 participants

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430

Phase 1

Completed

interventional

Dec 201296 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations